Does AMIODARONE Cause Pulmonary fibrosis? 886 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 886 reports of Pulmonary fibrosis have been filed in association with AMIODARONE (Amiodarone Hydrochloride). This represents 3.5% of all adverse event reports for AMIODARONE.
886
Reports of Pulmonary fibrosis with AMIODARONE
3.5%
of all AMIODARONE reports
335
Deaths
446
Hospitalizations
How Dangerous Is Pulmonary fibrosis From AMIODARONE?
Of the 886 reports, 335 (37.8%) resulted in death, 446 (50.3%) required hospitalization, and 199 (22.5%) were considered life-threatening.
Is Pulmonary fibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMIODARONE. However, 886 reports have been filed with the FAERS database.
What Other Side Effects Does AMIODARONE Cause?
Drug ineffective (2,223)
Dyspnoea (2,182)
Off label use (1,608)
Drug interaction (1,589)
Asthenia (1,452)
Interstitial lung disease (1,421)
Hyperthyroidism (1,410)
Fatigue (1,269)
Bradycardia (1,261)
Atrial fibrillation (1,211)
What Other Drugs Cause Pulmonary fibrosis?
METHOTREXATE (2,912)
ADALIMUMAB (2,277)
RITUXIMAB (2,192)
ETANERCEPT (1,926)
TOCILIZUMAB (1,886)
ABATACEPT (1,828)
HYDROXYCHLOROQUINE (1,740)
LEFLUNOMIDE (1,731)
PREDNISONE (1,692)
INFLIXIMAB (1,595)
Which AMIODARONE Alternatives Have Lower Pulmonary fibrosis Risk?
AMIODARONE vs AMISULPRIDE
AMIODARONE vs AMITRIPTYLINE
AMIODARONE vs AMITRIPTYLINE\PERPHENAZINE
AMIODARONE vs AMIVANTAMAB
AMIODARONE vs AMIVANTAMAB-VMJW